Advances in serum‐free media for CHO cells: From traditional serum substitutes to microbial‐derived substances
Biotechnology Journal · 2024-06 · 19 (6)
DOI: 10.1002/biot.202400251 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Journal, online erschienen am 21.06.2024. Verfasst von Mingcan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory…. Hauptthemen laut MEDLINE: Cricetulus, Recombinant Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: Guangdong Major Project of Basic and Applied Basic Research, GDAS' Special Project of Science and Technology Development, National Key Research and Development Program of China.
Abstract (Originalsprache)
The Chinese hamster ovary (CHO) cell is an epithelial‐like cell that produces proteins with post‐translational modifications similar to human glycosylation. It is widely used in the production of recombinant therapeutic proteins and monoclonal antibodies. Culturing CHO cells typically requires the addition of a certain proportion of fetal bovine serum (FBS) to maintain cell proliferation and passaging. However, serum is characterized by its complex composition, batch‐to‐batch variability, high cost, and potential risk of exogenous contaminants such as mycoplasma and viruses, which impact the purity and safety of the synthesized proteins. Therefore, search for serum alternatives and development of serum‐free media for CHO‐based protein biomanufacturing are of great significance. This review systematically summarizes the application advantages of CHO cells and strategies for high‐density expression. It highlights the developmental trends of serum substitutes from human platelet lysates to animal‐free extracts and microbial‐derived substances and elucidates the mechanisms by which these substitutes enhance CHO cell culture performance and recombinant protein production, aiming to provide theoretical guidance for exploring novel serum alternatives and developing serum‐free media for CHO cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Micro…
- Department of Food Science and Technology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Qingping Wu
Förderung
- Guangdong Major Project of Basic and Applied Basic Research
- GDAS' Special Project of Science and Technology Development
- National Key Research and Development Program of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhang, M., Zhao, X., Li, Y., Ye, Q., Wu, Y., Niu, Q., Zhang, Y., Fan, G., Chen, T., Xia, J., & Wu, Q. (2024). Advances in serum‐free media for CHO cells: From traditional serum substitutes to microbial‐derived substances. Biotechnology Journal, 19(6). https://doi.org/10.1002/biot.202400251
Vancouver
Zhang M, Zhao X, Li Y, Ye Q, Wu Y, Niu Q, et al. Advances in serum‐free media for CHO cells: From traditional serum substitutes to microbial‐derived substances. Biotechnology Journal. 2024;19(6). doi:10.1002/biot.202400251
BibTeX
@article{Zhang2024,
author = {Zhang, Mingcan and Zhao, Xinyu and Li, Ying and Ye, Qinghua and Wu, Yuwei and Niu, Qinya and Zhang, Ying and Fan, Guanghan and Chen, Tianxiang and Xia, Jiarui and Wu, Qingping},
title = {Advances in serum‐free media for CHO cells: From traditional serum substitutes to microbial‐derived substances},
journal = {Biotechnology Journal},
year = {2024},
volume = {19},
number = {6},
doi = {10.1002/biot.202400251}
}
EUVIMED